Research Paper Volume 15, Issue 20 pp 11489—11507
Anti-cancer targets and molecular mechanisms of formononetin in treating osteosarcoma based on network pharmacology
Figure 6. (A, B) The bar chart and bubble chart showing top 20 GO ID. (C, D) The bar chart and bubble chart showing the top 20 KEGG pathways of potential target genes of Form in OS.